title: The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors.
abstract: Brain death is associated with altered cardiac function and low concentrations of circulating triiodothryronine (T3). However, the effects of T3 administration on hemodynamic status and cardiac function in potential heart donors remain controversial. Thirty-seven brain-dead patients were randomly and blindly allocated to receive an intravenous bolus of either 0.2 microgram/kg T3 (n = 19) or saline placebo (n = 18). Measurements included conventional hemodynamic and echocardiographic variables of cardiac volume conditions and systolic function of the left ventricle (fractional area change [FAC], velocity of myocardial fiber shortening) using a transesophageal probe, arterial and mixed venous blood gas parameters, and serum thyroid hormone concentrations. The mean concentration of T3 was 1.86 +/- 1.55 pmol/L, and only six patients (16%) had normal values of T3 in control conditions. There was no significant correlation between T3 concentration and FAC (R = 0.17, not significant). All patients receiving T3 had normalized serum T3 concentration (7.55 +/- 2.56 pmol/L) in contrast to patients receiving saline (1.48 +/- 1.26 pmol/L). No significant differences in hemodynamic and echocardiographic parameters were observed between the placebo and T3 groups. Indeed, FAC remained unchanged after T3 (44% +/- 17% vs 46% +/- 22%) or placebo (47% +/- 18% vs 50% +/- 14%) administration. In 20 patients with impaired left ventricular function (FAC < 50%), FAC remained unchanged after T3 (n = 10; 34% +/- 12% vs 30% +/- 10%) or placebo (n = 10; 38% +/- 12% vs 35% +/- 13%) administration. In 17 patients in whom organ harvesting was delayed, transesophageal echocardiography was performed 6 h later and no significant changes in FAC were noted in the T3 group (n = 8; 49% +/- 17% vs 44% +/- 17%) and the placebo group (n = 9; 51% +/- 18% vs 47% +/- 18%). In conclusion, T3 administration did not improve hemodynamic status and myocardial function in brain-dead patients, suggesting that the euthyroid sick syndrome is not the main determinant of myocardial dysfunction in these patients.
authors.affiliation: Department of Anesthesiology, CHU Pitié-Salpêtrière, Paris VI University, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Goarin
authors.forename: S
authors.initials: S
authors.lastname: Cohen
authors.forename: B
authors.initials: B
authors.lastname: Riou
authors.forename: Y
authors.initials: Y
authors.lastname: Jacquens
authors.forename: R
authors.initials: R
authors.lastname: Guesde
authors.forename: F
authors.initials: F
authors.lastname: Le Bret
authors.forename: A
authors.initials: A
authors.lastname: Aurengo
authors.forename: P
authors.initials: P
authors.lastname: Coriat
mesh_terms: D000293:Adolescent; D000328:Adult; D001926:Brain Death / Q000503:physiopathology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D011446:Prospective Studies; D014019:Tissue Donors; D014284:Triiodothyronine / Q000494:pharmacology*
chemical_list: D014284:Triiodothyronine